Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PARTIAL AGONIST ACTIVITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 20 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Benyassi, A; Schwartz, C; Ducouret, B; Falcon, J
      Glucocorticoid receptors and serotonin N-acetyltransferase activity in thefish pineal organ

      NEUROREPORT
    2. Song, LN; Huse, B; Rusconi, S; Simons, SS
      Transactivation specificity of glucocorticoid versus progesterone receptors - Role of functionally different interactions of transcription factors with amino- and carboxyl-terminal receptor domains

      JOURNAL OF BIOLOGICAL CHEMISTRY
    3. Malminiemi, K
      Long-term celiprolol therapy lowers fasting plasma leptin levels

      CARDIOVASCULAR DRUGS AND THERAPY
    4. Huang, YC; Yeh, JL; Wu, BN; Lo, YC; Liang, JC; Lin, YT; Sheu, SH; Chen, IJ
      Ferulidilol: A vasodilatory and antioxidant adrenoceptor and calcium entryblocker, with ancillary beta(2)-agonist activity

      DRUG DEVELOPMENT RESEARCH
    5. Jakubetz, J; Schmuck, S; Poller, U; Fuchs, B; Gorf, A; Radke, J; Ponicke, K; Brodde, OE
      Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta(1)- and/or beta(2)-adrenoceptor mediated?

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    6. Gigoux, V; Escrieut, C; Fehrentz, JA; Poirot, S; Maigret, B; Moroder, L; Gully, D; Martinez, J; Vaysse, N; Fourmy, D
      Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin

      JOURNAL OF BIOLOGICAL CHEMISTRY
    7. Wurch, T; Colpaert, FC; Pauwels, PJ
      G-protein activation by putative antagonists at mutant Thr(373)Lys alpha(2A) adrenergic receptors

      BRITISH JOURNAL OF PHARMACOLOGY
    8. WU BN; HUANG YC; WU HM; HONG SJ; CHIANG LC; CHEN IJ
      A HIGHLY SELECTIVE BETA(1)-ADRENERGIC BLOCKER WITH PARTIAL BETA(2)-AGONIST ACTIVITY DERIVED FROM FERULIC ACID, AN ACTIVE COMPONENT OF LIGUSTICUM-WALLICHII FRANCH

      Journal of cardiovascular pharmacology
    9. SHEU MM; WU BN; HO WC; HONG SJ; CHEN SJ; LIN YT; CHEN IJ
      VANIDILOL - A VANILLOID-TYPE VASORELAXANT AND OCULAR HYPOTENSIVE BETA-ADRENOCEPTOR BLOCKER WITH PARTIAL BETA-2-AGONIST ACTIVITY

      Pharmacology
    10. LIMA JJ
      RELATIONSHIP BETWEEN BETA-ADRENOCEPTOR OCCUPANCY AND RECEPTOR DOWN-REGULATION INDUCED BY BETA-ANTAGONIST WITH INTRINSIC SYMPATHOMIMETIC ACTIVITY

      Journal of receptor and signal transduction research
    11. MALMINIEMI K
      ASSOCIATION BETWEEN SERUM-LIPIDS, GLUCOSE-TOLERANCE, AND INSULIN SENSITIVITY DURING 12 MONTHS OF CELIPROLOL TREATMENT

      Cardiovascular drugs and therapy
    12. HOSOHATA Y; SASAKI K; SHEN Y; HATTORI K; SUZUKI J; NAGATOMO T
      BOPINDOLOL IS A SLOWLY DISSOCIATING BETA(1)-ADRENOCEPTOR ANTAGONIST WHEN COMPARED TO OTHER BETA-BLOCKERS

      Biological & pharmaceutical bulletin
    13. HOSOHATA Y; SASAKI K; SUZUKI M; KARAKISAWA Y; MARUYAMA K; TSUCHIHASHI H; NAGATOMO T
      ALPHA-1 AND BETA-ADRENERGIC-RECEPTOR BLOCKING POTENCIES OF BOPINDOLOLAND ITS 2 METABOLITES (18-502 AND 20-785) AS ASSESSED BY RADIOLIGAND BINDING ASSAY-METHODS

      General pharmacology
    14. ABDEEN OA; TAYLOR BK; YOUNGBLOOD KL; PRINTZ MP
      PERIPHERAL BETA-ADRENERGIC-BLOCKADE MODIFIES AIRPUFF STARTLE-INDUCED HEART-RATE RESPONSES

      The Journal of pharmacology and experimental therapeutics
    15. HOSOHATA Y; SUZUKI M; KARAKISAWA Y; MARUYAMA K; NAGATOMO T
      THE AFFINITY OF BOPINDOLOL AND ITS 2 METABOLITES FOR A BETA(2)-ADRENOCEPTOR IN THE BOVINE MESENTERIC

      Biological & pharmaceutical bulletin
    16. CHANNER KS; JAMES MA; MACCONNELL T; REES JR
      BETA-ADRENOCEPTOR BLOCKERS IN ATRIAL-FIBRILLATION - THE IMPORTANCE OFPARTIAL AGONIST ACTIVITY

      British journal of clinical pharmacology
    17. ABIKO Y; GOTOH H; YOKOYAMA T; ABIKO T; HASHIZUME H; AKIYAMA K
      BOPINDOLOL AND ITS METABOLITE 18-502 ATTENUATE REGIONAL MYOCARDIAL ACIDOSIS DURING PARTIAL OCCLUSION OF THE CORONARY-ARTERY IN DOGS

      Archives internationales de pharmacodynamie et de therapie
    18. LAROCHELLE CD; GIUDICELLI JF; BERDEAUX A
      DIFFERENTIAL-EFFECTS OF CELIPROLOL AND ATENOLOL ON LARGE EPICARDIAL CORONARY-ARTERIES IN CONSCIOUS DOGS AT REST AND DURING EXERCISE

      Journal of cardiovascular pharmacology
    19. SILVENTEPOIROT S; DUFRESNE M; VAYSSE N; FOURMY D
      THE PERIPHERAL CHOLECYSTOKININ RECEPTORS

      European journal of biochemistry
    20. OKUHIRA M; NAKAZAWA M; KAMEDA H; HARA K; KAWADA T; IMAI S
      BETA-BLOCKING ACTION OF BOPINDOLOL, A NEW BETA-BLOCKER, AND ITS ACTIVE METABOLITES IN OPEN-CHEST DOGS

      Archives internationales de pharmacodynamie et de therapie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 14:46:04